UK Cell & Gene Therapy Cold Chain Logistics Market Analysis to 2028: Dominated by Atelerix, Life Science Group, and Cryoport UK

Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Cold Chain Logistics Market, Competition, Forecast & Opportunities, 2028" report has been added to's offering.

The United Kingdom's cell & gene therapy cold chain logistics market is poised for substantial growth, marked by a surge in demand for cell and gene therapies, advancements in cold chain technology, and proactive government policies fostering a conducive environment for research innovation. The market's expansion is further nurtured by an increase in clinical trials, ensuring the safe and efficient transportation of complex therapies requiring controlled temperatures.

Increasing Clinical Trials and Approvals Amplify Demand for Specialized Logistics

The rise in the number of clinical trials and regulatory approvals for cell and gene therapies has catalyzed the need for specialized cold chain logistics solutions in the UK. With nearly 23,372 clinical trials in various phases and the historical approval of a gene therapy in 2012, the United Kingdom is at the forefront of cell and gene therapy innovation. This growing sector necessitates the maintenance of therapy integrity during transport, prioritizing cold chain logistics' role in delivering these therapies safely and effectively.

Advanced Cold Chain Technologies

Technological advancements have invigorated the UK cell and gene therapy cold chain logistics market. Market leaders like DHL, World Courier, and Biocair provide a suite of services ranging from temperature-controlled packaging to state-of-the-art monitoring solutions, ensuring the essential stability of cell therapies. This technology-driven approach not only supports industry growth but has also been critical during health crises like the COVID-19 pandemic, underscoring the importance of robust vaccine and therapy distribution networks.

Government Initiatives Promote Market Growth

Government initiatives and a solid regulatory framework have propelled the UK as a global hub for cell and gene therapy R&D. The interventions by the Medicines and Healthcare Products Regulatory Agency (MHRA), including the Accelerated Access Pathway and continuous investment into the sector, have bolstered market expansion. The establishment of a Cell and Gene Therapy Catapult Innovation Centre with significant government funding exemplifies the commitment to nurturing this vital industry sector.

Emergence of Latest Technological Trends

Automation, real-time tracking, cloud-based logistics management, blockchain, and artificial intelligence have emerged as key trends revitalizing the UK cell and gene therapy cold chain logistics market. These trends mark a leap towards increased efficiency, safety, and proactive management within the industry, ensuring therapies reach the end-user in optimal condition.

Market Growth Segmentation and Prospects

  • Segregation by component, services, transportation mode, temperature control, and end-user
  • Detailed categorizations including cryogenic shipping, temperature-controlled storage, and packaging
  • Comprehensive coverage by region – From Scotland to East Midlands

Key Players Shaping the Market

United Kingdom's cell & gene therapy cold chain logistics market landscape features key industry players including Atelerix Ltd., Life Science Group Ltd, and Cryoport UK Limited. These companies are spearheading the provision of critical logistics solutions aligned with the latest technological trends.

Key Attributes

Report AttributeDetails
No. of Pages82
Forecast Period2023-2028
Estimated Market Value (USD) in 2023$77.3 Million
Forecasted Market Value (USD) by 2028$180.72 Million
Compound Annual Growth Rate15.2%
Regions CoveredUnited Kingdom

A selection of companies mentioned in this report includes:

  • Atelerix Ltd.
  • Life Science Group Ltd. (LSG)
  • Arvato Group
  • DGP Intelius Ltd.
  • QuickSTAT (A Kuehne + Nagel Company)
  • TrakCel
  • Cryoport UK Limited
  • Patheon UK Limited (Thermo Fischer Scientific UK)
  • Catalent UK

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


United Kingdom Cell & Gene Therapy Cold Chain Logistics Market